Its been the most beautiful experience, she shared
These included CT-996, a once-daily oral small-molecule oral GLP-1 receptor agonist, in Phase I, for treating obesity in patients with and without Type 2 diabetes, as well as two injectable clinical drug candidates: CT-388, a once-weekly subcutaneous injectable in Phase II, for treating obesity in patients with and without Type 2 diabetes, and CT-868, a once-daily subcutaneous injectable, in Phase II, for treating Type 1 diabetes patients with overweight or obesity
Sun Protection: Glycolic acid increases skin sensitivity to sunlight, so its crucial to apply a broad-spectrum sunscreen with SPF 50 or higher daily, even on cloudy days
The Adaptation Response Your body possesses remarkable adaptive capacity
While GLP-1s like Wegovy are generally considered heart-healthy for many, they can also cause a slight increase in resting heart rate